SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-03-000031
Filing Date
2003-08-13
Accepted
2003-08-13 12:35:49
Documents
9
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 06/30/03 10Q ligand060310q.htm 10-Q 351825
3 EX 10.257 ex10-257.txt EX-10 28540
4 EX 10.258 ex10-258.txt EX-10 28716
5 EX 10.259 ex10-259.txt EX-10 5314
6 EX 10.260 ex10-260.txt EX-10 32955
7 EX 99.1 ex99-1.txt EX-99 3107
8 EX 99.2 ex99-2.txt EX-99 3093
9 EX 99.3 ex99-3.txt EX-99 1477
10 EX 99.4 ex99-4.txt EX-99 1459
  Complete submission text file 0000886163-03-000031.txt   458832
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 03839863
SIC: 2834 Pharmaceutical Preparations